Skip to main content

Blood Glucose

0
Pipeline Programs
7
Companies
7
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

7 companies ranked by most advanced pipeline stage

Dexcom
DexcomCA - San Diego
2 programs
Intravenous Blood Glucose monitoring systemN/A1 trial
subcutaneous continuous glucose sensorN/A1 trial
Active Trials
NCT00906490Completed100Est. May 2010
NCT05255783Completed40Est. May 2023
Purdue Pharma
Purdue PharmaCT - Stamford
1 program
Acute beverageN/A1 trial
Active Trials
NCT01951287Completed54Est. Sep 2015
Innovation Pharmaceuticals
1 program
Beverage 1N/A1 trial
Active Trials
NCT07103083Recruiting18Est. Oct 2025
Edwards Lifesciences
1 program
Intravenous Blood Glucose monitoring systemN/A
iNova Pharmaceuticals
iNova PharmaceuticalsAustralia - Chatswood
1 program
LIBERALN/A1 trial
Active Trials
NCT01033916Completed200Est. Jul 2016
Alliance Pharmaceuticals
1 program
LactisoleN/A1 trial
Active Trials
NCT01121783Unknown24Est. May 2011
Fresenius Kabi
Fresenius KabiGermany - Bad Homburg
1 program
Lactulose crystals 10 gN/A1 trial
Active Trials
NCT02968498Completed24Est. Feb 2017

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Innovation PharmaceuticalsBeverage 1
Dexcomsubcutaneous continuous glucose sensor
Fresenius KabiLactulose crystals 10 g
Purdue PharmaAcute beverage
Alliance PharmaceuticalsLactisole
iNova PharmaceuticalsLIBERAL
DexcomIntravenous Blood Glucose monitoring system

Clinical Trials (7)

Total enrollment: 460 patients across 7 trials

NCT07103083Innovation PharmaceuticalsBeverage 1

Postprandial Response to Fruit Juice

Start: Jul 2025Est. completion: Oct 202518 patients
N/ARecruiting
NCT05255783Dexcomsubcutaneous continuous glucose sensor

The Performance of Dexcom G6 Glucose Monitoring in Critically Ill Patients

Start: Nov 2021Est. completion: May 202340 patients
N/ACompleted
NCT02968498Fresenius KabiLactulose crystals 10 g

Blood Glucose Response After Oral Intake of Lactulose in Healthy Volunteers

Start: Nov 2016Est. completion: Feb 201724 patients
N/ACompleted
NCT01951287Purdue PharmaAcute beverage

Impact of Fluid Milk on Post-meal Glycemia and Insulinemia in Overwt/Obese Adults

Start: Aug 2013Est. completion: Sep 201554 patients
N/ACompleted
NCT01121783Alliance PharmaceuticalsLactisole

The Effect of Lactisole on the Responses to Glucose Solution

Start: May 2010Est. completion: May 201124 patients
N/AUnknown
NCT01033916iNova PharmaceuticalsLIBERAL

Strict or Liberal Insulin Protocol Following Coronary Artery Bypass Graft (CABG) Surgery

Start: Dec 2009Est. completion: Jul 2016200 patients
N/ACompleted
NCT00906490DexcomIntravenous Blood Glucose monitoring system

Clinical Study of the Intravenous Blood Glucose System in Hospitalized Adult Elective or Non-Emergent Surgery and Medical/Surgical Intensive Care Unit Patients

Start: Jun 2009Est. completion: May 2010100 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 460 patients
7 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.